Biophytis SA (BPTS) stock surged in the Pre-market; here is why?
Biophys SA (BPTS) stock gained in the pre-market after announcing that ANVISA has approved its Covid-19 treatment. BPTS values at $5.28, gaining more than 13.5%
Biophys SA (BPTS) stock gained in the pre-market after announcing that ANVISA has approved its Covid-19 treatment. BPTS values at $5.28, gaining more than 13.5%
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.